Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) NSE

Currency In INR

AD

Valuation

Market Cap420.17M
Enterprise Value417.11M
P/E Ratio20.97
PEG Ratio0.05
Price/Sales Ratio2.05
Price/Book Ratio2.71
Enterprise/Revenue2.04
Enterprise/EBITDA16.36

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.1
Operating Margin0.01
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.14

Income Statement

Revenue283.95M
Revenue/Share17.4
Gross Profit10.37M
EBITDA6.49M
Net Income27.86M
Diluted EPS1.71

Balance Sheet

Total Cash33.26M
Total Cash/Share2.04
Total Debt30.2M
Total Debt/Equity0.14
Current Ratio1.73
Book Value Per Share13.21

Price History

52-Week Change-23.62
52-Week High48.5
52-Week Low25.6
Moving Average 50 Days34.18
Moving Average 200 Days35.23

Statistics

Average Volume65,480
Shares Outstanding16.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD